Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Corvus Pharmaceuticals (CRVS) Shares Issued (2023 - 2025)

Historic Shares Issued for Corvus Pharmaceuticals (CRVS) over the last 3 years, with Q2 2025 value amounting to $35.5 million.

  • Corvus Pharmaceuticals' Shares Issued changed N/A to $35.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $37.9 million, marking a year-over-year increase of 38386.27%. This contributed to the annual value of $18.6 million for FY2024, which is 13702.66% up from last year.
  • Per Corvus Pharmaceuticals' latest filing, its Shares Issued stood at $35.5 million for Q2 2025.
  • Corvus Pharmaceuticals' Shares Issued's 5-year high stood at $35.5 million during Q2 2025, with a 5-year trough of $4000.0 in Q1 2023.
  • Over the past 3 years, Corvus Pharmaceuticals' median Shares Issued value was $1.3 million (recorded in 2023), while the average stood at $7.6 million.